Literature DB >> 30191441

Oral glucose load and mixed meal feeding lowers testosterone levels in healthy eugonadal men.

Thiago Gagliano-Jucá1, Zhuoying Li2, Karol M Pencina2, Yusnie M Beleva2, Olga D Carlson3, Josephine M Egan3, Shehzad Basaria2.   

Abstract

PURPOSE: Precise evaluation of serum testosterone levels is important in making an accurate diagnosis of androgen deficiency. Recent practice guidelines on male androgen deficiency recommend that testosterone be measured in the morning while fasting. Although there is ample evidence regarding morning measurement of testosterone, studies that evaluated the effect of glucose load or meals were limited by inclusion of hypogonadal or diabetic men, and measurement of testosterone was not performed using mass spectrometry.
METHODS: Sixty men (23-97 years) without pre-diabetes or diabetes who had normal total testosterone (TT) levels underwent either an oral glucose tolerance test (OGTT) or a mixed meal tolerance test (MMTT) after an overnight fast. Serum samples were collected before and at regular intervals for 2 h (OGTT cohort) or 3 h (MMTT cohort). TT was measured by LC-MS/MS. LH and prolactin were also measured.
RESULTS: TT decreased after a glucose load (mean drop at nadir = 100 ng/dL) and after a mixed meal (drop at nadir = 123 ng/dL). Approximately 11% of men undergoing OGTT and 56% undergoing MMTT experienced a transient decrease in TT below 300 ng/dL, the lower normal limit. Testosterone started declining 20 min into the tests, with average maximum decline at 60 min. Most men still had TT lower than baseline at 120 min. This effect was independent of changes in LH or prolactin.
CONCLUSION: A glucose load or a mixed meal transiently, but significantly, lowers TT levels in healthy, non-diabetic eugonadal men. These findings support the recommendations that measurement of serum testosterone to diagnose androgen deficiency should be performed while fasting.

Entities:  

Keywords:  Hypogonadism; LH; Mixed meal tolerance test; Oral glucose tolerance test; Sex hormones; Testosterone

Mesh:

Substances:

Year:  2018        PMID: 30191441      PMCID: PMC6445266          DOI: 10.1007/s12020-018-1741-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  33 in total

1.  Standardization of hormonal assays for the 21st century.

Authors:  Leonard Wartofsky; David J Handelsman
Journal:  J Clin Endocrinol Metab       Date:  2010-12       Impact factor: 5.958

2.  Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline.

Authors:  Shalender Bhasin; Glenn R Cunningham; Frances J Hayes; Alvin M Matsumoto; Peter J Snyder; Ronald S Swerdloff; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2006-05-23       Impact factor: 5.958

3.  Activities and attitudes of participants in the Baltimore longitudinal study.

Authors:  J L Stone; A H Norris
Journal:  J Gerontol       Date:  1966-10

4.  Sex hormone responses in healthy men and male patients with chronic obstructive pulmonary disease during an oral glucose load.

Authors:  A Hjalmarsen; U Aasebø; A Aakvaag; R Jorde
Journal:  Scand J Clin Lab Invest       Date:  1996-11       Impact factor: 1.713

5.  Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors.

Authors:  R C Gaillard; D Turnill; P Sappino; A F Muller
Journal:  Endocrinology       Date:  1990-07       Impact factor: 4.736

6.  S-testosterone decrease after a mixed meal in healthy men independent of SHBG and gonadotrophin levels.

Authors:  M Lehtihet; S Arver; I Bartuseviciene; A Pousette
Journal:  Andrologia       Date:  2012-04-23       Impact factor: 2.775

Review 7.  Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity.

Authors:  Paresh Dandona; Sandeep Dhindsa
Journal:  J Clin Endocrinol Metab       Date:  2011-09       Impact factor: 5.958

8.  Testosterone concentrations in diabetic and nondiabetic obese men.

Authors:  Sandeep Dhindsa; Michael G Miller; Cecilia L McWhirter; Donald E Mager; Husam Ghanim; Ajay Chaudhuri; Paresh Dandona
Journal:  Diabetes Care       Date:  2010-03-03       Impact factor: 19.112

9.  Prolactin suppresses luteinizing hormone secretion and pituitary responsiveness to luteinizing hormone-releasing hormone by a direct action at the anterior pituitary.

Authors:  C Y Cheung
Journal:  Endocrinology       Date:  1983-08       Impact factor: 4.736

10.  Intratesticular delivery of tumor necrosis factor-alpha and ceramide directly abrogates steroidogenic acute regulatory protein expression and Leydig cell steroidogenesis in adult rats.

Authors:  Victoria Morales; Pino Santana; Raquel Díaz; Carlos Tabraue; Germán Gallardo; Félix López Blanco; Inmaculada Hernández; Luisa F Fanjul; Carlos M Ruiz de Galarreta
Journal:  Endocrinology       Date:  2003-07-31       Impact factor: 4.736

View more
  1 in total

1.  Short-time intensive insulin therapy upregulates 3 beta- and 17 beta-hydroxysteroid dehydrogenase levels in men with newly diagnosed T2DM.

Authors:  Yun Hu; Ying Wang; Ting-Ting Cai; Lu Liu; Dong-Mei Li; Jian-Hua Ma; Bo Ding
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-19       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.